Exacerbation of lymphomatoid papulosis during rituximab therapy. (29th November 2012)

• Record Type: Journal Article
• Authors: McCurdy, Olivia; McCormack, Chris; Ritchie, David; Prince, H. Miles
• Is Part Of: Australasian journal of dermatology. Volume 55:Number 1(2014:Feb.)
• Page Start: e1
• Page End: e3
• Publication Date: 2012-11-29
• Subjects: Dermatology -- Periodicals; Dermatology -- Australasia -- Periodicals; 616.5005
• DOI: 10.1111/ajd.12002
• Languages: English
• ISSNs: 0004-8380

Abstract

<abstract abstract-type="main"> <title>Abstract</title> <p>We report two cases of lymphomatoid papulosis (LyP) occurring in conjunction with B‐cell lymphoproliferative malignancies where the LyP was exacerbated during rituximab (anti‐CD20 antibody)‐based therapy. We postulate that the altered B‐cell cytokine milieu acted to allow an exacerbation of the patient's concomitant T‐cell disease and discuss the possible mechanisms by which this may have occurred.</p> </abstract>